# An Extension Study of LON002 in Patients With Cancer

> **NCT02390986** · NA · UNKNOWN · sponsor: **LondonPharma Ltd.** · enrollment: 50 (estimated)

## Conditions studied

- Solid Tumours

## Interventions

- **DRUG:** LON002

## Key facts

- **NCT ID:** NCT02390986
- **Lead sponsor:** LondonPharma Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2015-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02390986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02390986, "An Extension Study of LON002 in Patients With Cancer". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT02390986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*